- Disease: Acute COVID-19
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Retrospective
- Objective: To describe the characteristics and clinical outcomes of highest risk patients with COVID-19 receiving early COVID-19 treatments in Scotland
- Number of participants enrolled: 2548
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Primary care
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Monoclonal antibodies
- Nirmatrelvir/Ritonavir
- Sotrovimab
- Molnupiravir
External Links
Other information
Funders/Sponsors:
- GSK
- Vir Biotechnology
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to